gadobutrol

FDA Drug Profile — gadobutrol, Gadavist

gadobutrol is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand names including gadobutrol, Gadavist. Available dosage form: injection.

Drug details

Generic Name
gadobutrol
Brand Names
gadobutrol, Gadavist
Application Number
ANDA217480
Sponsor
Slate Run Pharmaceuticals, LLC
NDC Codes
19
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
GADOBUTROL

Indications and Usage

1 INDICATIONS AND USAGE Gadobutrol Injection is indicated for: Magnetic resonance imaging (MRI) of the central nervous system (CNS) to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity in adult and pediatric patients including term neonates MRI of the breast to assess the presence and extent of malignant breast disease in adult patients Magnetic resonance angiography (MRA) to evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients including term neonates Cardiac MRI (CMRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD) Gadobutrol Injection is a gadolinium-based contrast agent indicated for use with magnetic resonance imaging (MRI): To detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system in adult and pediatric patients, including term neonates To assess the presence and extent of malignant breast disease in adult patients To evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients including term neonates To assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD). ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.